Petrus Trust Company’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,559
Closed -$456K 672
2024
Q3
$456K Buy
+4,559
New +$456K 0.04% 267